HK1046848B - Specific therapeutic composition for treating aids - Google Patents

Specific therapeutic composition for treating aids

Info

Publication number
HK1046848B
HK1046848B HK02107734.4A HK02107734A HK1046848B HK 1046848 B HK1046848 B HK 1046848B HK 02107734 A HK02107734 A HK 02107734A HK 1046848 B HK1046848 B HK 1046848B
Authority
HK
Hong Kong
Prior art keywords
therapeutic composition
specific therapeutic
treating aids
aids
treating
Prior art date
Application number
HK02107734.4A
Other languages
Chinese (zh)
Other versions
HK1046848A1 (en
Inventor
李叔文
Original Assignee
李叔文
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 李叔文 filed Critical 李叔文
Publication of HK1046848A1 publication Critical patent/HK1046848A1/en
Publication of HK1046848B publication Critical patent/HK1046848B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK02107734.4A 2000-03-03 2002-10-24 Specific therapeutic composition for treating aids HK1046848B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2000/000043 WO2001064211A1 (en) 2000-03-03 2000-03-03 Specific therapeutic composition for treating aids

Publications (2)

Publication Number Publication Date
HK1046848A1 HK1046848A1 (en) 2003-01-30
HK1046848B true HK1046848B (en) 2006-04-13

Family

ID=4574635

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02107734.4A HK1046848B (en) 2000-03-03 2002-10-24 Specific therapeutic composition for treating aids

Country Status (4)

Country Link
CN (1) CN1213747C (en)
AU (1) AU2000231423A1 (en)
HK (1) HK1046848B (en)
WO (1) WO2001064211A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0212405D0 (en) * 2002-05-29 2002-07-10 Insignion Holdings Ltd Composition and its therapeutic use
ITTO20040329A1 (en) * 2004-05-18 2004-08-18 Franco Deraco USE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DISEASES DERIVED FROM INFECTION FROM HERPES VIRUS, PAPILLOMA VIRUS, HEPATITIS VIRUS, NEURAL DISEASES OF VIRAL ORIGIN, DYSPLASIA OF VIRAL ORIGIN, DYSPLASIA OF VIRAL ORIGIN, IMMUN VIRAL FORMS
CN1895671B (en) * 2005-12-08 2012-11-28 淮北辉克药业有限公司 Compound preparation for treating viral liver disease
US20160279161A1 (en) * 2013-11-14 2016-09-29 Newsouth Innovation Pty Limited Senescence and senescence associated secretory phenotype
KR20180006389A (en) 2015-04-28 2018-01-17 뉴사우쓰 이노베이션스 피티와이 리미티드 NAD + targeting for the treatment of chemotherapy and radiotherapy induced cognitive impairment, neuropathy and inactivity
FR3075037B1 (en) 2017-12-20 2020-07-17 Pierre Fabre Dermo-Cosmetique COMBINATION OF A RETINOIDE AND AN EXTRACT OF SILYBUM MARIANUM (L.) GAERTN

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL84387A0 (en) * 1987-11-06 1990-02-09 Rapaport Erich Pharmaceutical compositions containing a substituted phosphatide
WO1991003246A1 (en) * 1989-09-11 1991-03-21 Wisconsin Alumni Research Foundation Novel use of vitamin d compounds to inhibit replication of the aids virus
DE4204108C2 (en) * 1992-02-12 1998-09-24 Kragler Peter Medicaments for the treatment and / or prophylaxis of disorders of folate metabolism
DE4204102C2 (en) * 1992-02-12 1998-09-24 Kragler Peter Medicines for the treatment and / or prophylaxis of AIDS and other related diseases
DE4218572A1 (en) * 1992-06-05 1993-12-09 Asta Medica Ag Synergistic combination of drugs containing as active ingredient alpha-lipoic acid, dihydrolipoic acid, their metabolites as well as the oxidized and reduced enantiomers of alpha-lipoic acid such as R-alpha-lipoic acid or S-alpha-lipoic acid and metabolites of alpha-lipoic acid with vitamins A, B1 -6, B12, C and E
CN1061239C (en) * 1995-01-20 2001-01-31 李叔文 Agent with special effect for curing Acquired Immunity Deficiency Syndrome

Also Published As

Publication number Publication date
CN1213747C (en) 2005-08-10
CN1434710A (en) 2003-08-06
WO2001064211A1 (en) 2001-09-07
HK1046848A1 (en) 2003-01-30
AU2000231423A1 (en) 2001-09-12

Similar Documents

Publication Publication Date Title
GB0023983D0 (en) Therapeutic compounds
GB0008710D0 (en) Therapeutic compounds
GB0016681D0 (en) Therapeutic compounds
GB0028264D0 (en) Well treatment
EP1296698A4 (en) Therapeutic agents - ii
GB0028269D0 (en) Well treatment
PL362855A1 (en) Improved treatment
EG25829A (en) Novel treatment
GB0002386D0 (en) Therapeutic composition
GB0028583D0 (en) Therapeutic compounds
GB0030845D0 (en) Novel treatment
AU5735701A (en) Seed treatment composition
GB0001710D0 (en) Therapeutic treatment
HK1046848A1 (en) Specific therapeutic composition for treating aids
AU2096002A (en) Therapeutic treatment
GB0029125D0 (en) Novel treatment
GB0031321D0 (en) Treatment
EP1303281A4 (en) Methods of treatment
GB0013105D0 (en) Therapeutic compounds
GB0019728D0 (en) Novel treatment
HU0003973D0 (en) Pharmaceutical composition for the treatment of aids
GB0006974D0 (en) Novel treatment
GB0029122D0 (en) Novel treatment
GB0029127D0 (en) Novel treatment
GB0020669D0 (en) Alopica treatment

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130303